Quidelortho Corp (QDEL)

Jun 3, 2025, 4:10 PM EDT - 1 day ago

QuidelOrtho Announces Strategy to Accelerate Growth in Molecular Diagnostics

May 22, 2025, 4:30 PM EDT - 13 days ago

QuidelOrtho to Participate in Upcoming Investor Conferences

May 12, 2025, 9:30 AM EDT - 23 days ago

QuidelOrtho: Stagnant Growth Means Best To Avoid (Rating Downgrade)

May 7, 2025, 7:56 PM EDT - 4 weeks ago

QuidelOrtho Corporation (QDEL) Q1 2025 Earnings Call Transcript

May 7, 2025, 4:05 PM EDT - 4 weeks ago

QuidelOrtho Reports First Quarter 2025 Financial Results

Apr 23, 2025, 4:30 PM EDT - 6 weeks ago

QuidelOrtho to Report First Quarter 2025 Financial Results

Mar 10, 2025, 9:00 AM EDT - 3 months ago

QuidelOrtho® Introduces Results Manager™ System

Feb 24, 2025, 7:00 AM EST - 3 months ago

QuidelOrtho to Participate in the 46th Annual Raymond James Institutional Investor Conference

Feb 12, 2025, 7:50 PM EST - 4 months ago

QuidelOrtho Corporation (QDEL) Q4 2024 Earnings Call Transcript

Feb 12, 2025, 4:05 PM EST - 4 months ago

QuidelOrtho Reports Fourth Quarter and Full-Year 2024 Financial Results

Jan 13, 2025, 9:00 AM EST - 5 months ago

QuidelOrtho Announces Preliminary Unaudited Revenue for Fourth Quarter 2024

Jan 7, 2025, 12:48 AM EST - 5 months ago

Kuehn Law Encourages Investors of QuidelOrtho Corporation to Contact Law Firm

Dec 31, 2024, 7:00 AM EST - 5 months ago

QuidelOrtho to Present at the 43rd Annual J.P. Morgan Healthcare Conference

Dec 10, 2024, 7:00 AM EST - 6 months ago

QuidelOrtho Announces Appointment of Two Independent Directors to its Board

Nov 20, 2024, 3:08 PM EST - 7 months ago

Carlyle Sells QuidelOrtho Shares, Analyst Sees Overhang Lifted

Nov 20, 2024, 8:06 AM EST - 7 months ago

Powell Industries Reports Weak Sales, Joins Target, QuidelOrtho And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session

TGT POWL

Nov 19, 2024, 9:05 PM EST - 7 months ago

QuidelOrtho Corporation Announces Pricing of Secondary Offering of Common Stock by the Carlyle Group

Nov 19, 2024, 4:54 PM EST - 7 months ago

QuidelOrtho Corporation Announces Secondary Offering of Common Stock by the Carlyle Group

Nov 11, 2024, 6:18 AM EST - 7 months ago

Top 4 Health Care Stocks That May Plunge This Quarter

AIRS NUVB PODD

Nov 7, 2024, 8:54 PM EST - 7 months ago

QuidelOrtho Corporation (QDEL) Q3 2024 Earnings Call Transcript

Nov 7, 2024, 4:05 PM EST - 7 months ago

QuidelOrtho Reports Third Quarter 2024 Financial Results

Oct 28, 2024, 7:00 AM EDT - 7 months ago

QuidelOrtho to Participate in Three Upcoming Investor Conferences

Oct 17, 2024, 7:00 AM EDT - 8 months ago

QuidelOrtho to Report Third Quarter 2024 Financial Results

Oct 9, 2024, 7:00 AM EDT - 8 months ago

QuidelOrtho Announces New R&D Executive Leader

Sep 10, 2024, 7:00 AM EDT - 9 months ago

QuidelOrtho Appoints Lee Bowman as Chief Human Resources Officer

Aug 29, 2024, 7:00 AM EDT - 10 months ago

VITROS® Syphilis Assay Now Available on VITROS 3600 Immunodiagnostic System, VITROS 5600 and VITROS XT 7600 Integrated Systems in the U.S.

Jul 31, 2024, 9:02 PM EDT - 11 months ago

QuidelOrtho Corporation (QDEL) Q2 2024 Earnings Call Transcript

Jul 31, 2024, 4:05 PM EDT - 11 months ago

QuidelOrtho Reports Second Quarter 2024 Financial Results

Jul 23, 2024, 7:17 PM EDT - 11 months ago

Avantor Set to Join S&P MidCap 400; QuidelOrtho & Schneider National to Join S&P SmallCap 600

APO AVTR HIBB SNDR SPGI

Jul 17, 2024, 7:00 AM EDT - 11 months ago

QuidelOrtho to Report Second Quarter 2024 Financial Results

Jun 11, 2024, 4:00 PM EDT - 1 year ago

The Schall Law Firm Encourages Investors Who Have Suffered Losses In QuidelOrtho Corporation To Make Contact

Jun 11, 2024, 10:30 AM EDT - 1 year ago

DEADLINE TODAY: The Schall Law Firm Encourages Investors in QuidelOrtho Corporation with Losses to Contact the Firm

Jun 10, 2024, 3:44 PM EDT - 1 year ago

DEADLINE REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of QuidelOrtho

Jun 10, 2024, 10:50 AM EDT - 1 year ago

DEADLINE TOMORROW: The Schall Law Firm Encourages Investors in QuidelOrtho Corporation with Losses to Contact the Firm

Jun 9, 2024, 11:00 AM EDT - 1 year ago

The Schall Law Firm Urges Investors Who Have Experienced Losses In QuidelOrtho Corporation To Get In Touch

Jun 8, 2024, 11:00 AM EDT - 1 year ago

The Schall Law Firm Encourages Investors Who Have Suffered Losses in QuidelOrtho Corporation to Make Contact

Jun 6, 2024, 11:00 AM EDT - 1 year ago

The Schall Law Firm Urges Investors With Losses In QuidelOrtho Corporation To Reach Out

Jun 5, 2024, 7:30 PM EDT - 1 year ago

QuidelOrtho (QDEL) Investors Who Suffered Substantial Losses After QDEL Reported Disastrous Q4 2023 Results, Terminated CEO, & Withdrew FDA Submission Should Contact Hagens Berman Before June 11, 2024 Deadline

Jun 4, 2024, 11:00 AM EDT - 1 year ago

QDEL DEADLINE APPROACHING: The Schall Law Firm Encourages Investors in QuidelOrtho Corporation with Losses to Contact the Firm

Jun 2, 2024, 11:00 AM EDT - 1 year ago

CRUCIAL DEADLINE REMINDER: The Schall Law Firm Encourages Investors in QuidelOrtho Corporation with Losses to Contact the Firm

Jun 1, 2024, 11:00 AM EDT - 1 year ago

IMPORTANT DEADLINE APPROACHING: The Schall Law Firm Encourages Investors in QuidelOrtho Corporation with Losses to Contact the Firm

May 31, 2024, 11:00 AM EDT - 1 year ago

DEADLINE ACTION NOTICE: The Schall Law Firm Encourages Investors in QuidelOrtho Corporation with Losses to Contact the Firm